Global pharmaceutical company, Cadila Healthcare has announced the launch of Trastuzumab Emtansine, the first Antibody Drug Conjugate (ADC) biosimilar for treating both early and advanced HER2 positive breast cancer. The company will market the drug under the brand name Ujvira. HER2 positive breast cancer is considered an aggressive form and constitutes 20 to 25% of…
The Maharashtra government has told the Aurangabad bench of the Bombay High Court on Monday that the treatment of mucormycosis or black fungus, will now be treated for free under the Mahatma Jotiba Phule Jan Aarogya Yojana and the Pradhan Mantri Jan Arogya Yojana. According to reports, citizens will receive free treatment for mucormycosis at…
The first batch of the adjunct COVID therapy drug, 2-deoxy-D-glucose (2-DG) which was developed by the Defence Research and Development Organisation (DRDO) in partnership with Dr Reddy’s Laboratories (DRL), Hyderabad, was released on Monday for emergency use. An anti-COVID-19 therapeutic application of the drug 2-DG has been developed by the Institute of Nuclear Medicine and Allied…
“COVID-19 is a recent disease and at times it displays symptoms which no other viral infection does. While we are developing an understanding of the short and long-term impact on the body we now know that one may develop new symptoms six months to one year after recovering from COVID. The term given to this…
Daniel B Smith, the Charge D’Affaires of the US embassy, said on Tuesday that the USA is looking for joint production of Johnson & Johnson Covid-19 vaccine in India and is also trying to figure out ways to boost manufacturing of the vaccines by vaccine producers like the Serum Institute of India (SII). In an announcement last month, the White…
In order to scale up production of Covid-19 vaccines, scaling up partnerships, technology transfers and supply of various critical equipment and materials is necessary to cater to the huge demand for vaccines said Bharat Biotech Joint MD Suchitra Ella on Saturday. Ella, speaking at the EU-India Business Roundtable said that more emphasis should be on fostering…
Global digital health company, Curatio, has responded to the urgent need for patient support in India with its unique platform that delivers evidence-based information and programs embedded with social and mental health support. Officially launched on May 6th, the company’s Stronger Together app has specifically designed programs and support for COVID survivors and long-haulers. The…
In face of the rising COVID cases in the country, Indian pharmaceutical company Bajaj Healthcare has announced the launch of its anti-viral drug Favipiravir, under the brand name Favijaj for the treatment of ‘mild to moderate COVID-19 patients’. This comes as the country is in the midst of a second wave of the coronavirus pandemic that…
Gilead’s Remdesivir, the popular antiviral drug that was widely hailed as a potential treatment for COVID-19, has reportedly been suspended by the World Health Organisation (WHO) from its list of medicines. As per reports, WHO has suspended Gilead’s Remdesivir from its ‘prequalification list’, an official list of medicines used as a standard for procurement by…
The Government has been constantly urging the citizens to get vaccinated against Covid-19 as it will help in immunizing the population and curbing the spread of the virus. The extent of the spread of the pandemic and the number of mortalities are at an all-time high in India. Therefore, the Centre on Friday released a…